Many cellular processes -including proliferation, differentiation, motility and the outgrowth of processes -are regulated by tyrosine phosphorylation of critical substrates. The catalytically opposed activities of proteintyrosine kinases and protein-tyrosine phosphatases maintain an essential balance of phosphorylation levels. In general, tyrosine phosphatases have higher constitutive activity than tyrosine kinases, suggesting that they may maintain a low level of tyrosine phosphorylation that is punctuated by bursts of tyrosine kinase activity.
Many cellular processes -including proliferation, differentiation, motility and the outgrowth of processes -are regulated by tyrosine phosphorylation of critical substrates. The catalytically opposed activities of proteintyrosine kinases and protein-tyrosine phosphatases maintain an essential balance of phosphorylation levels. In general, tyrosine phosphatases have higher constitutive activity than tyrosine kinases, suggesting that they may maintain a low level of tyrosine phosphorylation that is punctuated by bursts of tyrosine kinase activity.
We shall focus on the interactions between receptorlinked protein-tyrosine phosphatases and both extracellular ligands and intracellular substrates. Receptor tyrosine phosphatases each have a large extracellular region, similar to those of cell adhesion molecules (CAMs), linked via a transmembrane spanning segment to cytoplasmic tyrosine phosphatase domains. Recent studies show that the extracellular domain of the receptor tyrosine phosphatase RPTP3 (also known as PTPS) interacts with three neural cell adhesion molecules [1] [2] [3] . The cytoplasmic domains of two other receptor tyrosine phosphatases, PTPp. and DPTP1OD, interact with transmembrane proteins that are substrates for their enzymatic activities [4, 5] . The repercussions of the binding of ligand to the extracellular domain of a receptor tyrosine phosphatase have not yet been defined; binding to ligands could modulate phosphatase activity and/or relocalize receptor tyrosine phosphatases within cells to bring them into contact with potential substrates.
Interactions between ligands and the extracellular domains of receptor tyrosine phosphatases
Studies of cell aggregation using transfected cell lines have revealed that PTPIz and PTPK are homophilic adhesion molecules [6] . The extracellular domains of these receptor tyrosine phosphatases have identical organizations, consisting of a MAM (meprin/a5/jL) domain, an immunoglobulin-like domain, and four fibronectin type III (FN3) repeats. When transfected cells expressing PTPt are mixed with cells expressing PTPK, the two types of cells coalesce into discrete homogenous aggregates. Despite their structural similarity, therefore, the homophilic binding properties of PTP.t and PTPK are highly specific [7] .
Some receptor tyrosine phosphatases can mediate heterophilic adhesion: for example, the extracellular domain of RPTPI interacts with several neural cell adhesion molecules (Fig. 1) . The extracellular region of RPTPP3 is composed of an amino-terminal carbonic anhydrase (CAH)-like domain, a single FN3 repeat, and a large 'spacer' domain [8, 9] . RPTP is a chondroitin sulfate proteoglycan expressed in three forms, one secreted and two membrane-bound [9, 10] . The soluble form of the extracellular domain, known as phosphacan, is produced by translation of an alternatively spliced RPTP3 mRNA [10] . Phosphacan binds at least three ligands: the widely expressed neural adhesion molecules N-CAM and Ng-CAM (L1, NILE) and the extracellular matrix molecule tenascin [1, 2] . The interactions of phosphacan with these proteins may be mediated by the spacer domain, as isolated CAH and FN3 domains do not confer binding ( Fig. la) [3] . Removal of the chondroitin sulfate moieties of phosphacan demonstrates that the core protein is both necessary and sufficient for phosphacan-CAM binding [1] .
A more recent study [3] , using both expression cloning and affinity purification techniques, has demonstrated that contactin (F3/F11) is a neuronal ligand for the RPTPP CAH domain (Fig. la) . Like the phosphacan/RPTPI3 ligands N-CAM and Ng-CAM, contactin is a member of the immunoglobulin superfamily [11] . Contactin-expressing chick tectal neurons adhere to, and extend neurites on, substrates made up of RPTP3 CAH domains. CAH domain substrates also induce the differentiation of a human neuroblastoma cell line. Significantly, contactinspecific antibodies inhibit differentiation of these cells and cause neurite retraction [3] . These results show that engagement of contactin by the RPTPI3 CAH domain activates a signal transduction pathway that instructs specific cells to adopt a neuronal fate and extend processes.
RPTPP is widely expressed on glial cells in the central and peripheral nervous systems [12] . Interactions in vivo between RPTPP and contactin must be restricted to localized regions of the brain, however, because contactin is expressed only on specific axon pathways during development [13, 14] . It is not clear whether the enzymatic activity or intracellular localization of RPTPI is altered by engagement of contactin. In contrast to the RPTPPmediated activation of contactin signaling, phosphacan inhibits both N-CAM-and Ng-CAM-mediated adhesion of glia and neurons; moreover, phosphacan forms a nonpermissive substrate for neurite extension [1] . These data suggest that binding to the extracellular domain of RPTPI can block adhesion mediated by N-CAM and Ng-CAM. Phosphacan could also inhibit the interactions of contactin-expressing neurons with RPTP3-expressing glial cells. As RNA and protein analyses suggest that phosphacan is the predominant form of RPTP3 [10, 15] , these inhibitory interactions are likely to occur in vivo.
The outcomes of interactions between phosphacan/ RPTP3 and contactin are difficult to predict, because contactin is part of a large multiprotein complex and may transduce signals by way of interactions with Ng-CAM within the same complex [11] . It is also noteworthy that contactin is expressed both as a membrane-bound molecule anchored by a glycosylphosphatidylinositol (GPI) linkage and as a soluble protein, which is cleaved from the membrane [11] . Thus, it is unclear how a neuron expressing contactin, Ng-CAM and N-CAM would respond in vivo to contact with glial cells that express RPTP3 and/or secrete phosphacan. The interactions among neural cell adhesion molecules and RPTP3 isoforms are likely to be important, given the essential roles of neuron-glial communication during brain development.
Interactions with the cytoplasmic domains of receptor tyrosine phosphatases
Little is known about the signaling pathways downstream of receptor tyrosine phosphatases, but recent work has begun to identify proteins that interact with their cytoplasmic domains. These could be tyrosine phosphatase substrates whose activities are modulated by tyrosine phosphorylation; alternatively, associated proteins could act as localization signals for the tyrosine phosphatases. A recently identified cytoskeletal protein that interacts with the carboxyl terminus of the receptor tyrosine phosphatase LAR may be critical for LAR localization within cells [16] . Many tyrosine phosphatases do not exhibit high substrate specificity in vitro, so specificity in vivo may be determined in part by cellular compartmentalization.
PTPu, which is a homophilic adhesion molecule, associates with a protein complex containing cadherins and oa-and -catenins in both cultured cell and tissue lysates [4] . Cadherins are homophilic Ca 2 +-dependent adhesion molecules that associate with catenins; catenins, in turn, bind to the underlying actin cytoskeleton [17] . The cytoplasmic region of PTPu binds directly to E-cadherin in vitro (Fig. lb) . Moreover, PTPp[, cadherins and catenins are colocalized at points of cell-cell contact, including adherens junctions. Treatment of cells with pervanadate, which is a global tyrosine phosphatase inhibitor, produces a large increase in tyrosine phosphorylation of cadherins [4] . Taken together, the data suggest that the cadherins are endogenous substrates for PTP[p.
Cadherin-associated tyrosine phosphatases may be critical players in cell-cell interactions, as phosphotyrosine modification of the cadherin-catenin complex can alter its adhesive properties; increased tyrosine phosphorylation of cadherins weakens intercellular adhesion via adherens junctions [4] . Dephosphorylation of cadherins by PTPp-may be a constitutive process that is essential for maintaining junctional stability. On the intracellular face of the junction, interactions among cytoplasmic domains would ensure that PTPp. colocalizes with its substrate, cadherin. Externally, homophilic adhesion mediated by PTPI. could supplement homophilic cadherin adhesion. The avidity of intercellular adhesion could be modulated as required by signal-driven increases in tyrosine kinase activity that would transiently exceed the rate of cadherin dephosphorylation by receptor tyrosine phosphatases.
Studies in our laboratory have focused on identification of substrates for a set of Drosophila axonal receptor tyrosine phosphatases [18] . The cytoplasmic domain of one of these, DPTP1OD, binds in vitro to a 150 kD glycoprotein, gpl50, a transmembrane protein whose extracellular domain contains 18 leucine-rich repeat motifs homologous to those found in several Drosophila adhesion and signaling proteins (Fig. c) . These homologous proteins include chaoptin, which is involved in photoreceptor clustering, and connectin, an adhesion molecule expressed on a specific subset of motor neurons and their muscle targets [19] [20] [21] . The short cytoplasmic domain of gpl50 contains four tyrosine residues in sequence configurations that suggest they could bind to downstream signaling molecules containing Src homology 2 (SH2) domains. Phosphorylated gpl50 is a substrate in vitro for DPTP1OD [5] . Our recent results indicate that gp150 can be phosphorylated on tyrosine residues in vivo. Coexpression of DPTP1OD reverses this phosphorylation in a dose-dependent manner (our unpublished observations), suggesting that gp150 is a substrate for DPTP1OD in vivo. This interaction may modulate the activity of a downstream signal transduction pathway.
In summary, both the extracellular and cytoplasmic domains of receptor tyrosine phosphatases can interact with cell adhesion molecules, and these interactions have functional consequences for both adhesion and signal transduction.
